Synbias Pharma AG

Committed to quality

Driven by innovation

Following the recommendation of our legal counsel to increase transparency in business transactions we plan to publish the list of company’s ultimate beneficial owners in:

00
days
00
hours
00
minutes

Products

Each year, approximately 300 kg of Active Pharmaceutical Ingredients, from 100 grams to 150 kilograms, leave our company and are delivered to customers in 21 countries on 5 continents.

Our team has significant experience in route development, optimization, scale-up pilot, and commercial scale chemistry for GMP and non-GMP productions.

Anthracyclines

  • Doxorubicin Hydrochloride

  • Epirubicin Hydrochloride

  • Idarubicin Hydrochloride

  • Valrubicin

Nucleosides

  • Nelarabine

  • Cladribine (Under development)

API production

Our activities are under full compliance with the worldwide valid cGMP regulations. We can develop a manufacturing process for New Chemical Entities (NCE) and/or supply the active pharmaceutical ingredients for all phases of a drug’s life cycle, beginning with material for the first clinical studies up to the commercial supply. We assure the highest, consistent quality of our APIs to enable you to run an effective process for the production of your finished drug forms.

Quality system

Synbias Pharma implemented a Quality System to ensure product quality and patient safety throughout the entire life cycle of our products, which targets all relevant stages of material management, process development, scale up, and commercial API manufacturing and quality control.

Our Quality System is designed to fulfill Swissmedic, cGMP, FDA, and customer requirements.

Our management will be happy to answer your questions.

About Us

Synbias Pharma AG is a pharmaceutical company that focuses on modern manufacturing of Active Pharmaceutical Ingredients (APIs). The headquarters are located in Schaffhausen, Switzerland, with a manufacturing and R&D site in Mannheim, Germany (Gemini PharmChem Mannheim GmbH). Our customers include both generic and innovative pharma companies from five continents. Synbias Pharma is a leading global API supplier of anthracycline antibiotics with a 30-50% share of the world market.

Synbias Pharma’s primary specialization is developing and manufacturing highly potent APIs, mainly used for cancer therapy, including Anthracyclines, Nucleosides and Plant alkaloids. We can produce APIs according to the specific requirements of our customers. We optimize the production processes based on many years of experience and practice. Furthermore, we provide comprehensive support during registration.

Our business partners recognize us as a competent, reliable and efficient company that is distinguished by an innovative character and customized approach to services. The company’s world leading positions in its niche markets is based on the knowledge, skills, commitment and loyalty of its employees.

News

Want to keep up to date with the latest news?

Follow us. Read our news.

read news

Contacts

Pestalozzistrasse 2,

8200 Schaffhausen,

Switzerland